Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.14 USD | -0.80% | -2.49% | -8.90% |
May. 13 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
May. 10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.90% | 18.05B | |
-5.82% | 182B | |
+1.87% | 111B | |
-3.49% | 68.48B | |
+0.30% | 49.69B | |
+7.78% | 44.46B | |
+2.33% | 40.67B | |
+22.58% | 31.22B | |
+1.86% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Baxter International Says it has Secured FDA Clearance for Novum IQ Syringe Infusion Pump